Cargando…
Cost Effectiveness of Pharmacogenetic Testing for Drugs with Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines: A Systematic Review
The objective of this study was to evaluate the evidence on cost‐effectiveness of pharmacogenetic (PGx)–guided treatment for drugs with Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines. A systematic review was conducted using multiple biomedical literature databases from incepti...
Autores principales: | Morris, Sarah A., Alsaidi, Ashraf T., Verbyla, Allison, Cruz, Adilen, Macfarlane, Casey, Bauer, Joseph, Patel, Jai N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828439/ https://www.ncbi.nlm.nih.gov/pubmed/36149409 http://dx.doi.org/10.1002/cpt.2754 |
Ejemplares similares
-
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
por: Caudle, Kelly E., et al.
Publicado: (2017) -
Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical
Pharmacogenetics Implementation Consortium (CPIC) Guideline Development
Process
por: Caudle, Kelly E., et al.
Publicado: (2014) -
Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC(®)) Guidelines and a Commercial Pharmacogenetics Laboratory in Genotype to Phenotype Interpretations For Patients Utilizing Psychotropics
por: Blazy, Christopher, et al.
Publicado: (2022) -
Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines
por: Abdullah-Koolmees, Heshu, et al.
Publicado: (2021) -
Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
por: Pritchard, Daryl, et al.
Publicado: (2022)